Aspen Process Pulse™
あらゆる種類のプロセスデータやスペクトルデータをリアルタイムで可視化し、プロセスを監視、制御、最適化します。早期故障検出、プロセス逸脱警告、プロセス分析技術（PAT）サポート、そして継続的な改善のためのモデルを実行する一方で、規制上の義務の遵守も可能にします。
プロセスの仕組みに合わせて構築
単一ツールでプロセス全体を監視
リアルタイムのデータ分析
プロセス品質の確保
PAT Portfolio Honored with a Pharma Manufacturing 2021 Innovation Award
The award celebrates technologies contributing to advancements in risk reduction, product quality improvement and manufacturing efficiency.
関連製品
Aspen Unscrambler™
多変量統計解析とインタラクティブな可視化を用いてプロセスのモデル化、予測、最適化を行うことができます。
Aspen Unscrambler HSI™
ハイパースペクトル画像の探索的多変量解析によって複雑な問題を解決します。
Related Content
Digitalization for Pharmaceuticals: Safeguarding Product Supply by Ensuring Asset and Process Health
In the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to su...
White Paper
Unlocking the Value of PAT
The PAT (Process Analytical Technology) market is on track to more than double in size by 2023, yet many organizations have not unlocked PAT’s full potential. Watch this on-demand webinar to find out ...
On-Demand Webinar
Better Batch Monitoring
Batch processing requires supremely accurate monitoring to ensure successful batch completion. In the case of deviations, the ability to prevent unwanted process behavior from happening is critical to...
On-Demand Webinar
Better Blend Monitoring
If faced with inhomogeneous blends, manufacturers lose money and valuable time. Not to mention the possible risks of reblends and regulatory citations.
On-Demand Webinar
GlaxoSmithKline Speeds up Batch Release Time: A Study in Digital Transformation
GlaxoSmithKline (GSK) wanted to review the structure of its batch production record and associated workflows as part of a continuous improvement process. Reducing batch review time usually results in ...
Case Study
日本の製薬会社がAspen Plus®で 品質改善を実現
日本に本社を置き、創業から140年の歴史を誇るグローバル製薬会社がAspen Plusを導入して新規原薬（API）の合成を改善しました。同社は、創薬に重点を置きながら医薬品や医療機器の研究開発から製造、販売まで行っています。
Case Study
Solution Brief: Accelerate Market Growth with New Advances in Process Analytical Technology
Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supp...
White Paper